Stay updated on BGB324 in Recurrent Glioblastoma Surgery Clinical Trial
Sign up to get notified when there's something new on the BGB324 in Recurrent Glioblastoma Surgery Clinical Trial page.

Latest updates to the BGB324 in Recurrent Glioblastoma Surgery Clinical Trial page
- Check4 days agoChange DetectedAdded dedicated Locations sections listing participating sites by state (Alabama, Maryland, Michigan, New York, North Carolina, Pennsylvania) and updated the revision to v3.3.3. Removed the older state-location headings and the HHS Vulnerability Disclosure link, along with revision 3.3.2.SummaryDifference0.7%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed.SummaryDifference0.1%

- Check39 days agoChange DetectedThe page removed an administrative notice about government funding and NIH operating status that was previously displayed. The core study information and eligibility details remain unaffected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check54 days agoChange Detected- The ABTC Consortium termination is noted with an official close date of 10/31/2023. - The study record shows the latest update date as 2024-02-08.SummaryDifference0.4%

- Check82 days agoChange DetectedSummary of changes: updated operating status notice and a version bump to v3.2.0, replacing the previous v3.1.0.SummaryDifference3%

- Check90 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.SummaryDifference0.1%

Stay in the know with updates to BGB324 in Recurrent Glioblastoma Surgery Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BGB324 in Recurrent Glioblastoma Surgery Clinical Trial page.